The Philadelphia translocation and pre-existing myeloproliferative disorders

Br J Haematol. 2005 Mar;128(5):734-6. doi: 10.1111/j.1365-2141.2005.05396.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Humans
  • Hydroxyurea / therapeutic use
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Male
  • Middle Aged
  • Philadelphia Chromosome*
  • Piperazines / therapeutic use
  • Pyrimidines / therapeutic use
  • Thrombocythemia, Essential / complications
  • Thrombocythemia, Essential / drug therapy
  • Thrombocythemia, Essential / genetics*
  • Time Factors
  • Translocation, Genetic*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Hydroxyurea